Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
The terminal killer cell-independent lysis (KCIL) stage of the human natural killer (NK) lethal hit is blocked by the protease enzymes trypsin (T), chymotrypsin (CT), and papain (P). The present studies analyze the mechanism of inhibition of KCIL by these enzymes. The pretreatment of effector PBL with T or CT but not P effectively reduced the ability of these cells to mediate NK lysis. This was due at least in part to a reduced ability of the treated NK cells to bind the NK target K562. Pretreatment of K562 cells with T, CT, or P also abolished their ability to serve as targets due to reduced binding ability. These same enzyme-pretreated target cells, however, were unaffected in their ability to bind a natural killer cell-derived cytolytic factor (NKCF) molecule(s), as determined by direct NKCF absorption studies or by their ability to cold target compete for the binding of NKCF to another NKCF-sensitive cell, the L929 fibroblast, thereby indicating that the K562 "target antigen" and the NKCF-receptor are independently expressed structures. Furthermore, NKCF activity, as measured by its ability to kill either K562 or L929 cells, was sensitive to T and CT but resistant to P. These studies indicate that various proteases inhibit NK-KCIL by different mechanisms and suggest that the lethal hit is a complex process. The ability of P to inhibit KCIL but not affect NKCF activity or the target cell NKCF receptor implies that additional NK cell-derived materials may be required in the lethal hit during direct NK cell-mediated cytotoxicity. A model depicting a hypothetical molecular mechanism for human NK cytolysis is presented and discussed.
D001667:Binding, Competitive; D002918:Chymotrypsin / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism; D008233:Lymphotoxin-alpha / Q000378:metabolism / Q000494:pharmacology; D010206:Papain / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011971:Receptors, Immunologic / Q000187:drug effects; D014357:Trypsin / Q000494:pharmacology
D008233:Lymphotoxin-alpha; D011971:Receptors, Immunologic; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D014357:Trypsin; D010206:Papain